Top Story

BIOSCIENCE: Biodegradable polymer DES noninferior to durable polymer DES in 1-year TLF

September 3, 2014

BARCELONA, Spain — Sirolimus-eluting stents featuring a biodegradable polymer were noninferior to everolimus-eluting stents in reducing the rate of target lesion failure at 1 year, according to the BIOSCIENCE trial presented here.

The biodegradable polymer sirolimus-eluting stent (SES; Orsiro, Biotronik; n=1,063) includes a cobalt chromium platform with a 60-mcm strut thickness. In the BIOSCIENCE trial, Thomas Pilgrim, MD, with the Swiss Cardiovascular Center, University Hospital, Bern, Switzerland, and colleagues compared the stent to cobalt chromium everolimus-eluting stents (EES; Xience Prime/Xpedition, Abbott Vascular; n=1,056).

figure In the Journals

High leisure-time physical activity levels linked to reduced risk for HF

September 2, 2014
The more a person engages in leisure-time physical activity, the less risk they have for HF, according to new research.Researchers also found a similar but less…
In the Journals

Fenofibrate slows diabetic retinopathy progression in at-risk patients

September 2, 2014
Intensive treatment of glycemia and dyslipidemia slowed the progression of diabetic retinopathy in diabetic patients with cardiovascular disease or associated risk…
FDA News

Janssen expands Xarelto research program

September 2, 2014
Janssen Research & Development and Bayer HealthCare announced the expansion of the EXPLORER research program for Xarelto with a series of new clinical trials in…
More News Headlines »
CME

Managing Acute Ischemic Stroke in the Emergency Department: Two Decades of Progress

This activity is supported by an educational grant from Genentech.

12/30/2013
According to the American Heart Association Heart Disease and Stroke Statistics 2013 Update, approximately 795,000…
More »
Meeting News Coverage Video
figure

Biodegradable stents noninferior to durable polymer stents for percutaneous coronary revascularization

September 1, 2014
BARCELONA, Spain – Dipti Itchhaporia, MD, FACC, discusses results of the BIOSCIENCE trial, which compared a…
More »
CME

Challenges and Opportunities in the Treatment of Acute Ischemic Stroke

This activity is supported by an educational grant from Genentech.

12/27/2013
According to the American Heart Association Heart Disease and Stroke Statistics – 2013 Update, approximately 795,000…
More »